Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
01 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/01/2770774/0/en/Spexis-Announces-Changes-to-the-Executive-Committee.html
06 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/06/2755891/0/en/Spexis-to-host-business-update-conference-call-on-October-9-2023.html
29 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/29/2751738/0/en/Spexis-provides-business-update-and-announces-financial-results-for-the-first-half-of-2023.html
28 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/28/2750884/0/en/Spexis-announces-the-appointment-of-Gon%C3%A7alo-Bernardes-Ph-D-as-acting-Head-of-Chemical-Biology.html
15 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/08/15/2725169/0/en/Spexis-announces-USD-2-5-million-capital-commitment-to-support-the-upcoming-Phase-3-ColiFin-studies.html
30 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/30/2697522/0/en/Spexis-announces-engagement-with-Maxim-Group-LLC-as-M-A-advisor-to-support-evaluation-of-strategic-transactions.html
ABOUT THIS PAGE